Showing results (11-20 of 93) with videos related to
Sort By:
Pageof 10
Current HIV Research|June 17, 2011
Estimated liver fibrosis and its impact on all-cause mortality of HCV-monoinfected and HCV/HIV-coinfected drug usersA Sanvisens, D Fuster, I Serra, et al.Medicina Clinica|February 11, 1989
[Human immunodeficiency virus type 2 infection in Western Africans living in Catalonia]V Soriano, J Tor, R Muga, et al.Medicina Clinica|November 5, 1994
[HIV infection declines among intravenous drug addicts in Barcelona: 1987-1993]R Muga, J M Egea, J Tor, et al.Medicina Clinica|March 31, 1990
[Primary infection caused by human immunodeficiency virus: clinical and serologic aspects of 7 cases]V Soriano, J Tor, R Muga, et al.British Journal of Addiction|June 1, 1990
Natural history of parenteral drug addicts treated in a general hospitalR Muga, J Tor, C Ginesta, et al.Medicina Clinica|August 5, 2000
[Analysis of internal notices to the emergency team of the medical area at a general hospital]P Tudela, M J Rego, J Tor, et al.Medicina Clinica|October 12, 1991
[The evidence of human immunodeficiency virus infection in the seronegative subjects of high-risk groups]V Soriano, I Hewlett, J Tor, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 3, 2000
Mortality of HIV-positive and HIV-negative heroin abusers as a function of duration of injecting drug useR Muga, J Roca, J M Egea, et al.Medicina Clinica|January 27, 1996
[Rates of human immunodeficiency virus (HIV) infection in intravenous drug addicts from the Barcelona area, according to sex and age of drug consumption onset]J M Egea, J Tor, R Muga, et al.Epidemiology and Infection|February 27, 2009
Prospective evaluation of latent tuberculosis with interferon-gamma release assays in drug and alcohol abusersI Rivas, I Latorre, A Sanvisens, et al.Pageof 10